Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,244 | -39,719 | -29,045 | -17,465 | -7,348 |
| Accounts payable and accrued liabilities | -827 | 806 | 2,474 | 1,043 | -537 |
| Other Working Capital | -4,329 | 10,749 | 9,554 | 8,227 | 2,176 |
| Other Operating Activity | 1,016 | 46 | -1,820 | -585 | 783 |
| Operating Cash Flow | $-12,384 | $-28,119 | $-18,837 | $-8,781 | $-4,927 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -1 | N/A | N/A | N/A |
| Investing Cash Flow | $N/A | $-1 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70,081 | 20,945 | 20,945 | N/A | N/A |
| Financing Cash Flow | $70,081 | $20,945 | $20,945 | $N/A | $N/A |
| Beginning Cash Position | 6,117 | 13,291 | 13,291 | 13,291 | 13,291 |
| End Cash Position | 63,814 | 6,117 | 15,399 | 4,510 | 8,364 |
| Net Cash Flow | $57,698 | $-7,175 | $2,108 | $-8,781 | $-4,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,384 | -28,119 | -18,837 | -8,781 | -4,927 |
| Free Cash Flow | -12,384 | -28,119 | -18,837 | -8,781 | -4,927 |